Literature DB >> 1268547

Plasma nicotine levels after cigarette smoking and chewing nicotine gum.

M A Russell, C Feyerabend, P V Cole.   

Abstract

Plasma nicotine levels were measured over seven hours of smoking cigarettes (1-2 mg nicotine) in a single subject under standardised conditions, and were compared with the levels obtained from chewing-gum containing either 2 mg or 4 mg nicotine. Levels comparable to those resulting from smoking were not obtained with the 2-mg gum, but peak levels on the 4-mg gum averaged 40-1 ng/ml from the third gum onwards compared with 49-2ng/ml after cigarettes. Nicotine was absorbed much more slowly from the gum than from cigarettes. It took 15-30 minutes for the 4-mg gum to raise the plasma nicotine by an average of 11-9 ng/ml compared with an average increase of 27-8 ng/ml within two minutes of completing each cigarette. In a sample of 15 smokers attending a withdrawal clinic the average plasma nicotine concentration while taking 2-mg nicotine chewing-gum was only 10-8 ng/ml compared with 30-4 ng/ml two minutes after smoking a cigarette. Although plasma nicotine levels equivalent to those following cigarette smoking may be obtained by chewing at least 10 pieces of 4-mg nicotine gum daily, the slower rate of absorption may limit its therapeutic value as a substitute for cigarette smoking.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1268547      PMCID: PMC1639908          DOI: 10.1136/bmj.1.6017.1043

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


  9 in total

1.  Cigarette smoking and plasma levels of nicotine.

Authors:  P F Isaac; M J Rand
Journal:  Nature       Date:  1972-04-07       Impact factor: 49.962

2.  Comparison of increases in carboxyhaemoglobin after smoking "extra-mild" and "non-mild" cigarettes.

Authors:  M A Russell; C Wilson; P V Cole; M Idle; C Feyerabend
Journal:  Lancet       Date:  1973-09-29       Impact factor: 79.321

3.  Inhalation of tobacco smoke by pipe and cigar smokers.

Authors:  C M Castleden; P V Cole
Journal:  Lancet       Date:  1973-07-07       Impact factor: 79.321

4.  Absorption by non-smokers of carbon monoxide from room air polluted by tobacco smoke.

Authors:  M A Russell; P V Cole; E Brown
Journal:  Lancet       Date:  1973-03-17       Impact factor: 79.321

5.  Carbon-monoxide absorption by cigarette smokers who change to smoking cigars.

Authors:  J Cowie; R W Sillett; K Ball
Journal:  Lancet       Date:  1973-05-12       Impact factor: 79.321

6.  A substitute for tobacco smoking.

Authors:  O Fernö
Journal:  Psychopharmacologia       Date:  1973-07-19

Review 7.  A critical review and evaluation of smoking control methods.

Authors:  J L Schwartz
Journal:  Public Health Rep       Date:  1969-06       Impact factor: 2.792

8.  The role of nicotine as a determinant of cigarette smoking frequency in man with observations of certain cardiovascular effects associated with the tobacco alkaloid.

Authors:  B R Lucchesi; C R Schuster; G S Emley
Journal:  Clin Pharmacol Ther       Date:  1967 Nov-Dec       Impact factor: 6.875

9.  Effects of nicotine on electrocortical activity and acetylcholine release from the cat cerebral cortex.

Authors:  A K Armitage; G H Hall; C M Sellers
Journal:  Br J Pharmacol       Date:  1969-01       Impact factor: 8.739

  9 in total
  52 in total

1.  Cigarette smoking and nicotine delay postprandial mouth-cecum transit time.

Authors:  A M Scott; J E Kellow; G M Eckersley; J M Nolan; M P Jones
Journal:  Dig Dis Sci       Date:  1992-10       Impact factor: 3.199

2.  Psychomotor performance in smokers following single and repeated doses of nicotine gum.

Authors:  N Sherwood; J S Kerr; I Hindmarch
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

3.  Pharmacokinetics of multiple daily transdermal doses of nicotine in healthy smokers.

Authors:  H D Ross; K K Chan; A J Piraino; V A John
Journal:  Pharm Res       Date:  1991-03       Impact factor: 4.200

4.  The effects of nicotine on the human electroretinogram.

Authors:  Stefanie B Varghese; Jamie C Reid; E Eugenie Hartmann; Kent T Keyser
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-12-09       Impact factor: 4.799

Review 5.  Nicotine replacement therapy. What has been accomplished--can we do better?

Authors:  N L Benowitz
Journal:  Drugs       Date:  1993-02       Impact factor: 9.546

Review 6.  Clinical pharmacokinetics of nasal nicotine delivery. A review and comparison to other nicotine systems.

Authors:  N G Schneider; E Lunell; R E Olmstead; K O Fagerström
Journal:  Clin Pharmacokinet       Date:  1996-07       Impact factor: 6.447

Review 7.  Pharmacotherapy for tobacco cessation: nicotine agonists, antagonists, and partial agonists.

Authors:  Maher Karam-Hage; Paul M Cinciripini
Journal:  Curr Oncol Rep       Date:  2007-11       Impact factor: 5.075

Review 8.  The nicotine inhaler: clinical pharmacokinetics and comparison with other nicotine treatments.

Authors:  N G Schneider; R E Olmstead; M A Franzon; E Lunell
Journal:  Clin Pharmacokinet       Date:  2001       Impact factor: 6.447

9.  Nicotine chewing gum as a substitute for smoking.

Authors:  M A Russell; S R Sutton; C Feyerabend; P V Cole; Y Saloojee
Journal:  Br Med J       Date:  1977-04-23

Review 10.  Substance abuse vaccines.

Authors:  Frank M Orson; Berma M Kinsey; Rana A K Singh; Yan Wu; Tracie Gardner; Thomas R Kosten
Journal:  Ann N Y Acad Sci       Date:  2008-10       Impact factor: 5.691

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.